To date, numerous studies have been reported demonstrating improvement of heart function in support of this goal [ 1, 2].
Few studies have been reported demonstrating its effectiveness for weight loss, but research projects are in progress and some reports are beginning to appear [ 20].
In part, results of this study have already been reported demonstrating the impact of two different treatment strategies for early goal-directed fluid therapy [ 30].
Cooperative increase in tumorigenesis in cells co-expressing oncogenes and CK2 has also been reported demonstrating a critical role of CK2 in the progression of malignancies [ 6, 13].
Preliminary in vivo characterization of the inhibitors 12 and 14 is reported demonstrating that they raise brain anandamide levels following either intraperitoneal (ip) or oral (po) administration indicative of effective in vivo FAAH inhibition.
A collection of experimental studies involving interval information granules is reported demonstrating the main features of the proposed approach.
Finally, the performance of the model on a set of larger problems is reported, demonstrating its efficiency.
A detailed comparison of sodium, lactate and cortisol from saliva is reported, demonstrating the potential of the multi-sensing platform for tracking these outcomes.
Agreement percentages of 82% (nose) and 91% (throat) were reported, demonstrating excellent agreement.
Results from human-agent interactions are reported demonstrating the model's performance in learning, observation, imitation, and generation of gestures.
